Riedel Resources Ltd
ASX:RIE
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
|
Riedel Resources Ltd
ASX:RIE
|
AU |
|
Moleculin Biotech Inc
LSE:0K2H
|
US |
|
UMS Holdings Ltd
SGX:558
|
SG |
|
P
|
PTC Therapeutics Inc
SWB:BH3
|
US |
|
A
|
Aleafia Health Inc
OTC:ALEAF
|
CA |
|
PSP Swiss Property AG
LSE:0QO8
|
CH |
|
EnBW Energie Baden Wuerttemberg AG
LSE:0IHQ
|
DE |
|
Rhoen Klinikum AG
XETRA:RHK
|
DE |
|
I
|
Inspien Inc
KOSDAQ:465480
|
KR |
|
M
|
Macy's Inc
F:FDO
|
US |
|
Lanxess AG
F:LXS
|
DE |
|
C
|
Children's Place Inc
F:CP5
|
US |
|
Sulzer AG
OTC:SULZF
|
CH |
|
MS Industrie AG
F:MSAG
|
DE |
|
L
|
Lanxess AG
SWB:LXS
|
DE |
|
ESE Entertainment Inc
XTSX:ESE
|
CA |
|
Tanger Factory Outlet Centers Inc
NYSE:SKT
|
US |
Gewinn- und Verlustrechnung
Ergebnis-Wasserfall
Riedel Resources Ltd
Gewinn- und Verlustrechnung
Riedel Resources Ltd
| Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatz | |||||||||||||||||||||||||||||
| Zinsaufwand |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Umsatz |
0
N/A
|
0
-80%
|
0
-67%
|
0
+100%
|
0
+100%
|
0
+13%
|
0
-26%
|
0
-55%
|
0
-72%
|
0
+253%
|
0
-27%
|
0
-24%
|
0
-7%
|
0
-43%
|
0
+38%
|
0
-21%
|
0
-83%
|
0
-50%
|
0
-50%
|
0
+25%
|
0
-20%
|
0
+575%
|
0
+141%
|
0
+63%
|
0
-16%
|
0
-49%
|
0
-40%
|
0
+6.319%
|
|
| Operatives Ergebnis | |||||||||||||||||||||||||||||
| Operative Kosten |
(2)
|
(2)
|
(1)
|
(1)
|
(5)
|
(5)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(2)
|
(0)
|
(3)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(6)
|
(1)
|
(4)
|
|
| Vertriebs-, Verwaltungs- und Gemeinkosten |
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(3)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| F&E |
(1)
|
(0)
|
0
|
0
|
(5)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Abschreibungen |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Sonstige operative Kosten |
0
|
0
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
0
|
(4)
|
|
| Operatives Ergebnis |
(2)
N/A
|
(2)
+12%
|
(1)
+18%
|
(1)
+31%
|
(5)
-430%
|
(5)
+1%
|
(1)
+87%
|
(0)
+25%
|
(1)
-48%
|
(1)
-6%
|
(0)
+44%
|
(1)
-152%
|
(1)
+2%
|
(1)
+53%
|
(0)
+10%
|
(2)
-257%
|
(0)
+81%
|
(3)
-951%
|
(3)
-5%
|
(1)
+78%
|
(1)
+13%
|
(1)
-22%
|
(1)
-3%
|
(1)
-23%
|
(1)
+7%
|
(6)
-583%
|
(1)
+88%
|
(4)
-447%
|
|
| Vorsteuergewinn | |||||||||||||||||||||||||||||
| Zinserträge/-aufwendungen |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
|
| Nicht wiederkehrende Posten |
0
|
0
|
(3)
|
(7)
|
(3)
|
2
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(1)
|
0
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(5)
|
0
|
(4)
|
0
|
|
| Gewinn/Verlust aus Anlagenabgängen |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Sonstige Erträge gesamt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Vorsteuergewinn |
(2)
N/A
|
(2)
+12%
|
(4)
-161%
|
(8)
-89%
|
(8)
+7%
|
(3)
+55%
|
(1)
+77%
|
0
N/A
|
1
+6.941%
|
1
-1%
|
0
-80%
|
(1)
N/A
|
(1)
+6%
|
(0)
+23%
|
(2)
-253%
|
(2)
+7%
|
(1)
+30%
|
(4)
-253%
|
(3)
+13%
|
(1)
+79%
|
(1)
+1%
|
(1)
-9%
|
(1)
-3%
|
(1)
-20%
|
(6)
-548%
|
(6)
+1%
|
(4)
+30%
|
(4)
+6%
|
|
| Nettogewinn | |||||||||||||||||||||||||||||
| Steueraufwand |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Ergebnis aus fortgeführten Geschäftsbereichen |
(2)
|
(2)
|
(4)
|
(8)
|
(8)
|
(3)
|
(1)
|
0
|
1
|
1
|
0
|
(1)
|
(1)
|
(0)
|
(2)
|
(2)
|
(1)
|
(4)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(6)
|
(6)
|
(4)
|
(4)
|
|
| Ergebnisanteil Minderheitsgesellschafter |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Nettogewinn |
(2)
N/A
|
(2)
+12%
|
(4)
-161%
|
(8)
-89%
|
(8)
+7%
|
(3)
+55%
|
(1)
+77%
|
0
N/A
|
1
+6.941%
|
1
-1%
|
0
-80%
|
(1)
N/A
|
(1)
+6%
|
(0)
+23%
|
(2)
-253%
|
(2)
+7%
|
(1)
+30%
|
(4)
-253%
|
(3)
+13%
|
(1)
+79%
|
(1)
+1%
|
(1)
-9%
|
(1)
-3%
|
(1)
-18%
|
(6)
-554%
|
(6)
+1%
|
(4)
+35%
|
(4)
+7%
|
|
| Verwässertes EPS |
-1,16
N/A
|
-0,68
+41%
|
-1,67
-146%
|
-2,92
-75%
|
-2,69
+8%
|
-0,9
+67%
|
-0,2
+78%
|
0
N/A
|
0,12
N/A
|
0,11
-8%
|
0,02
-82%
|
-0,07
N/A
|
-0,06
+14%
|
-0,05
+17%
|
-0,16
-220%
|
-0,16
N/A
|
-0,1
+38%
|
-0,34
-240%
|
-0,21
+38%
|
-0,02
+90%
|
-0,03
-50%
|
-0,02
+33%
|
-0,02
N/A
|
-0,02
N/A
|
-0,11
-450%
|
-0,11
N/A
|
-0,07
+36%
|
-0,03
+57%
|
|